Given that the proteins PFKM, GAPDH, ACO2, and MDH2 have rate-limiting effects on aerobic oxidative metabolism, the decreased expression is consistent with the results of glucose metabolism disorders in diabetic patients. The gene discussed is PFKM; the disease is glucose metabolism disease.